Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 8:38 AM ET

Life Sciences Tools and Services

Company Overview of EMD Millipore Corporation

Company Overview

EMD Millipore Corporation provides solutions and services for research, development, and production of biotechnology and pharmaceutical drug therapies. It offers bioscience products and services that include antibodies and assays, protein detection and quantification, inhibitors and biochemicals, proteins and enzymes, cell culture and systems, genomic analysis, and cell analysis; lab solutions, such as chemical and reagents, IVD/OEM materials and reagents, microbiological testing and process monitoring, and related services; and process solutions, including sterile filtration, virus reduction, biopharma raw materials, drug delivery compounds, engineering, and validation services. The company...

290 Concord Road

Billerica, MA 01821-7037

United States

Founded in 1954

6,100 Employees

Phone:

781-533-6000

Fax:

781-533-3110

Key Executives for EMD Millipore Corporation

Chief Executive Officer and President
Head of Finance and Controlling
Head of Global Operations and Member of Management Board
Age: 60
Member of Management Board and President of Emd Millipore Division
Member of Management Board and Head of Emd Millipore's Bioscience Business Unit
Age: 48
Compensation as of Fiscal Year 2014.

EMD Millipore Corporation Key Developments

EMD Millipore Introduces Magna Chirp™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs

EMD Millipore introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA). The highly effective multiprobe-based capture strategy uses cross-linked chromatin to provide reliable detection and discovery of RNA-associated genomic DNA sequences, RNA sequences and proteins. The new kits use the ChIRP method (Chromatin Isolation by RNA Purification) to isolate chromatin complexes using RNA as the target, allowing researchers to pinpoint specific sites of genomic interaction for chromatin-associated RNAs. The kits simplify the ChIRP method, providing all necessary buffers, enzymes and reagents in one validated kit, as well as a negative control probe set and detailed protocol with capture probe design guidelines. In addition, first-time users can opt for the EZ-Magna ChIRP™ kit, which includes a positive control capture probe set and detection primers that make it easier to validate an experiment's success. The kits guide researchers through a process in which they cross-link and lyse cells, sonicate chromatin and hybridize biotinylated capture oligos, which bind to the complementary RNA sequence. Then, EMD Millipore's PureProteome™ Streptavidin magnetic beads are added, which are included in the kits to allow robust pull down of any chromatin binding to the target RNA. After the beads are washed, the DNA, RNA, and protein components can be isolated for further analysis. The protocol eliminates non-specific signals by utilizing split pools of capture probes (even/odd) to allow unambiguous identification of specific interactions.

EMD Millipore Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services

EMD Millipore announced an agreement for providing upstream process development services for Precision Biologics Inc. to advance a preclinical monoclonal antibody. The antibody, NEO-201, binds to a tumor-specific antigen found in several forms of cancer, offering therapeutic potential across multiple cancer types, including colorectal, lung, ovarian, and pancreatic, an especially deadly cancer with limited treatment options. Under the agreement, EMD Millipore will provide process development through its Provantage® Services offering, which leverages the company's deep expertise in biopharmaceutical manufacturing to help customers design and develop custom processes that improve yield and productivity while reducing costs and accelerating time to market. The process development will occur at EMD Millipore's single-use GMP biodevelopment center in Martillac, France.

EMD Millipore Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control

EMD Millipore announced the introduction of its AFS 40E /80E /120E and 150E water purification systems. These new systems have been developed to provide clinical laboratories with an economical and reliable water purification solution for daily water volumes of up to 3000 L. The AFS 40E /80E /120E and 150E systems rely on two powerful technologies to produce water quality meeting Clinical and Laboratory Standards Institute (CLSI) Clinical Laboratory Reagent Water standards. State-of-the-art, proven Elix electrodeionization (EDI) technology ensures constant water quality with low and predictable running costs, while unique E.R.A. (Evolutive Reject Adjustment) technology takes feed water quality into account in order to automatically optimize water recovery and reduce water usage costs. The AFS 40E /80E /120E and 150E systems also offer users powerful 24/7 real-time monitoring and remote control over their water purification systems, as well as a new generation of enhanced services. These advanced monitoring features, along with an unprecedented level of service, also help maximize water purification system and analyzer uptime. The systems have been designed to provide quick and precise remote diagnostics and offer proactive service in order to avoid downtime. Service starts with feed water analysis by a certified EMD Millipore Field Service Engineer prior to system installation. Then, over time, users can ensure the best upkeep of their AFS E water purification system with a customized Watercare Pact service plan. With its large new touch screen, the system is designed for intuitive operation and for supporting the user with easy step-by-step instructions during routine maintenance. Interacting with the water purification system has never been easier. For increased flexibility, the system interface can also be accessed from another location, using a PC, tablet, or smart phone through a web browser. Mobile and customizable, the new range of systems is designed to make the best use of lab space. The quiet, compact systems are mounted on wheels, and can be moved around the lab or to another location depending on current lab requirements. AFS E system users can choose from a number of options and accessories to match their specific requirements, including an online Total Organic Carbon (TOC) monitor, degassing option, and sanitary sampling valve, among others.

Similar Private Companies By Industry

Company Name Region
LightSpeed Genomics Inc United States
Active Life Scientific, Inc. United States
PBS Biotech, Inc. United States
AFID Therapeutics, Inc. United States
Oncopartners United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMD Millipore Corporation, please visit www.emdmillipore.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.